Jason Hannon will take the helm of Mainstay Medical Oct. 9, according to MarketsInsider.
Here are five highlights:
1. Mr. Hannon will replace current CEO Peter Crosby, who is retiring. Mr. Crosby will serve as a consultant to the company until the end of 2020.
2. Mr. Hannon will also serve as a director, effective Oct. 9.
3. With a 12-year career at NuVasive, Mr. Hannon served as the company's president and COO.
4. Mainstay Medical develops ReActiv8, an implantable restorative neurostimulation system.
5. The company is conducting the ReActiv8 clinical trial to gather data for its FDA pre-market approval application.